HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infliximab in a case of early adult-onset Still's disease.

AuthorsI Olivieri, G de Stefano, A Padula, A La Gala, C de Stefano
JournalClinical rheumatology (Clin Rheumatol) Vol. 22 Issue 4-5 Pg. 369-70 (Oct 2003) ISSN: 0770-3198 [Print] Germany
PMID14579170 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Infliximab
Topics
  • Adult
  • Antibodies, Monoclonal (administration & dosage)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Male
  • Risk Assessment
  • Severity of Illness Index
  • Still's Disease, Adult-Onset (diagnosis, drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: